Nuance

Nuance's CLU solution, which includes natural language processing capabilities that are tailored to the healthcare space, will "supplement" Watson's more general NLP abilities.

"What we're going to need to fully take advantage of Watson is to have the genetic and epigenetic information of patients so that the Watson program will be able to utilize and organize that also in medical decision making," said a researcher involved with IBM's efforts to develop an artificial intelligence system that can help doctors diagnose patients accurately and quickly.

The firms will combine technology that IBM developed for Watson, including deep question answering, natural language processing, and machine learning capabilities, with Nuance's speech recognition and Clinical Language Understanding solutions to help physicians diagnose and treat patients.

The partners will combine their respective technologies in an effort to provide hospitals, physicians, and payers access to critical and timely information with a potential role in personalized medicine.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.